InnerworldStanford researchers just developed an experimental intranasal vaccine that, in mice, defends the lungs for months against a range of viruses, bacteria, and even allergens
Incredible breakthrough if it holds up in human trials.
Stanford researchers just developed an experimental intranasal vaccine that, in mice, defends the lungs for months against a range of viruses, bacteria, and even allergens